VNUS® Medical Technologies, Inc. (Nasdaq:VNUS), a leading
provider of medical devices for the minimally invasive treatment of
venous reflux disease, announced today that it plans to report its
financial results for the first quarter ended March 31, 2009, before
market on May 8.
VNUS plans to host its regular quarterly teleconference at 5:30 a.m. PT
/ 8:30 a.m. ET on May 8. This call will also be webcast live for
investors and archived on the company's website at www.vnus.com.
HOW TO ACCESS THE LIVE TELECONFERENCE
To participate, please dial (480) 629-9819 approximately 5-10 minutes
before the teleconference is scheduled to begin. The operator will take
your name and connect your line with the meeting. A phone replay will be
available for seven days after the live call at (303) 590-3030, code
4061292.
HOW TO ACCESS THE TELECONFERENCE WEBCAST
Go to the home page of the VNUS investor relations website at http://ir.vnus.com/
and click on the webcast icon. From this site, you can listen to the
teleconference, assuming that your computer system is configured
properly.
ABOUT VNUS MEDICAL TECHNOLOGIES, INC.
VNUS is a leading provider of medical devices for the minimally invasive
treatment of venous reflux, a progressive condition caused by
incompetent vein valves in the leg. VNUS sells the Closure system, which
consists of a proprietary radiofrequency (RF) generator and proprietary
disposable endovenous catheters and devices to treat diseased veins
through the application of temperature-controlled RF energy. For more
information, please visit the corporate website at http://www.vnus.com.
VNUS Medical Technologies, Inc.
Peter Osborne, 408-360-7499
Chief
Financial Officer and Vice President of Finance and Administration
ir@vnus.com
